Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands : Towards LVAD destination therapy in the Netherlands?

Affiliations

O C Manintveld. Neth Heart J. 2015 Feb.

. 2015 Feb;23(2):100-1.

doi: 10.1007/s12471-014-0609-x.

¹ Thoraxcenter, Department of Cardiology, Erasmus Medical Center, PO Box 2040, 3000 CA, Rotterdam, the Netherlands, o.manintveld@erasmusmc.nl.

No abstract available

References

1. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International society for Heart and Lung Transplantation. 30th Adult heart transplant report - 2013. J Heart Lung Transplant. 2013;32:951–64. doi: 10.1016/j.healun.2013.08.006. - DOI - PubMed
1. Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant. 2014;33:555–64. doi: 10.1016/j.healun.2014.04.010. - DOI - PubMed
1. Haeck MLA, Beeres SLMA, Höke U et al. Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands. Neth Heart. 2014; 22. doi:10.1007/s12471-014-0602-4. - PMC - PubMed
1. Robertson JO, Grau-Sepulveda MV, Ikada S, et al. Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic surgeons database analysis. J Heart Lung Transplant. 2014;33:609–17. doi: 10.1016/j.healun.2014.01.861. - DOI - PubMed
1. Neyt M, van den Bruel A, Smit V, et al. Cost-effectiveness of continuous-flow left ventricular assist devices. Int J Technol Assess Health Care. 2013;29(3):254–60. doi: 10.1017/S0266462313000238. - DOI - PubMed